BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Enayathullah MG, Parekh Y, Banu S, Ram S, Nagaraj R, Kumar BK, Idris MM. Gramicidin S and melittin: potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection. Sci Rep 2022;12:3446. [PMID: 35236909 DOI: 10.1038/s41598-022-07341-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang M, Liu S, Zhang C. Antimicrobial peptides with antiviral and anticancer properties and their modification and nanodelivery systems. Current Research in Biotechnology 2023. [DOI: 10.1016/j.crbiot.2023.100121] [Reference Citation Analysis]
2 Oliveira I, Ferreira I, Jacob B, Cardenas K, Cerni F, Baia-da-Silva D, Arantes E, Monteiro W, Pucca M. Harnessing the Power of Venomous Animal-Derived Toxins against COVID-19. Toxins (Basel) 2023;15. [PMID: 36828473 DOI: 10.3390/toxins15020159] [Reference Citation Analysis]
3 Protić S, Kaličanin N, Sencanski M, Prodanović O, Milicevic J, Perovic V, Paessler S, Prodanović R, Glisic S. In Silico and In Vitro Inhibition of SARS-CoV-2 PL(pro) with Gramicidin D. Int J Mol Sci 2023;24. [PMID: 36768280 DOI: 10.3390/ijms24031955] [Reference Citation Analysis]
4 Banu S, Nagaraj R, Idris MM. A proteomic perspective and involvement of cytokines in SARS-CoV-2 infection. PLoS One 2023;18:e0279998. [PMID: 36608055 DOI: 10.1371/journal.pone.0279998] [Reference Citation Analysis]
5 Choi M, Cho H, Ahn B, Prathap S, Nagasundarapandian S, Park C. Genomewide Analysis and Biological Characterization of Cathelicidins with Potent Antimicrobial Activity and Low Cytotoxicity from Three Bat Species. Antibiotics 2022;11:989. [DOI: 10.3390/antibiotics11080989] [Reference Citation Analysis]
6 Akbarzadeh-Khiavi M, Torabi M, Olfati AH, Rahbarnia L, Safary A. Bio-nano scale modifications of melittin for improving therapeutic efficacy. Expert Opin Biol Ther 2022;:1-15. [PMID: 35687355 DOI: 10.1080/14712598.2022.2088277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ripperda T, Yu Y, Verma A, Klug E, Thurman M, Reid SP, Wang G. Improved Database Filtering Technology Enables More Efficient Ab Initio Design of Potent Peptides against Ebola Viruses. Pharmaceuticals 2022;15:521. [DOI: 10.3390/ph15050521] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]